Mina Sooch's most recent trade in Opus Genetics Inc. was a trade of 201,683 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 10, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 201,683 | 201,683 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 134,456 | 430,501 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 100,000 | 296,045 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 50,000 | 50,000 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 30,000 | 396,045 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | 06 Sep 2022 | 1,023 | 0 | - | - | Series B Warrant (right to buy) | ||
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | 06 Sep 2022 | 1,023 | 426,045 | - | 0 | Common Stock | ||
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.07 per share. | 19 May 2022 | 12,500 | 412,522 | - | 2.1 | 25,879 | Common Stock |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.02 per share. | 19 May 2022 | 12,500 | 425,022 | - | 2.0 | 25,300 | Common Stock |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 17,413 | 17,413 | - | - | Series A Warrant (right to buy) | |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 11,524 | 800,044 | - | - | Common Stock | |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 2,046 | 2,046 | - | - | Series B Warrant (right to buy) | |
| Opus Genetics Inc. | Mina Sooch | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 130,000 | 130,000 | - | - | Employee Stock Option (right to buy) |